| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6190927 | Clinical Radiology | 2013 | 6 Pages |
Abstract
Public concern erupted about the safety of Poly Implant Prothèse (PIP) breast implants when it was revealed in 2011 that they contained an inferior, unlicensed industrial-grade silicone associated with a high rate of rupture. There followed national guidance for UK clinicians, which led to a considerable increase in referrals of asymptomatic women for breast implant assessment. In this review we discuss possible approaches to screening the PIP cohort and the salient characteristics of a ruptured implant.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
V. Helyar, C. Burke, S. McWilliams,